Search Results - "Liu, Mitchell"

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial by Palma, David A, Olson, Robert, Harrow, Stephen, Gaede, Stewart, Louie, Alexander V, Haasbeek, Cornelis, Mulroy, Liam, Lock, Michael, Rodrigues, George B, Yaremko, Brian P, Schellenberg, Devin, Ahmad, Belal, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Moore, Karen, Currie, Suzanne, Schlijper, Roel, Bauman, Glenn S, Laba, Joanna, Qu, X Melody, Warner, Andrew, Senan, Suresh

“…The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites…”
Get full text

International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT) by Dunne, Emma M., Sahgal, Arjun, Lo, Simon S., Bergman, Alanah, Kosztyla, Robert, Dea, Nicolas, Chang, Eric L., Chang, Ung-Kyu, Chao, Samuel T., Faruqi, Salman, Ghia, Amol J., Redmond, Kristin J., Soltys, Scott G., Liu, Mitchell C.

“…•SBRT contouring recommendations for metastatic disease to the sacrum have been established.•High degree of agreement in target delineation among spine SBRT…”
Get full text

Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial by Palma, David A, Olson, Robert, Harrow, Stephen, Correa, Rohann J M, Schneiders, Famke, Haasbeek, Cornelis J A, Rodrigues, George B, Lock, Michael, Yaremko, Brian P, Bauman, Glenn S, Ahmad, Belal, Schellenberg, Devin, Liu, Mitchell, Gaede, Stewart, Laba, Joanna, Mulroy, Liam, Senthi, Sashendra, Louie, Alexander V, Swaminath, Anand, Chalmers, Anthony, Warner, Andrew, Slotman, Ben J, de Gruijl, Tanja D, Allan, Alison, Senan, Suresh

“…Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for patients with oligometastatic disease. SABR delivers precise, high-dose,…”
Get full text

Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial by Olson, Robert, Mathews, Lindsay, Liu, Mitchell, Schellenberg, Devin, Mou, Benjamin, Berrang, Tanya, Harrow, Stephen, Correa, Rohann J M, Bhat, Vasudeva, Pai, Howard, Mohamed, Islam, Miller, Stacy, Schneiders, Famke, Laba, Joanna, Wilke, Derek, Senthi, Sashendra, Louie, Alexander V, Swaminath, Anand, Chalmers, Anthony, Gaede, Stewart, Warner, Andrew, de Gruijl, Tanja D, Allan, Alison, Palma, David A

“…A recent randomized phase II trial evaluated stereotactic ablative radiotherapy (SABR) in a group of patients with a small burden of oligometastatic disease…”
Get full text

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases by Yeung, Rosanna, Hamm, Jeremy, Liu, Mitchell, Schellenberg, Devin

“…In limited metastatic burden of disease, stereotactic body radiotherapy (SBRT) has been shown to achieve high local control rates. It has been hypothesized…”
Get full text

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial by Palma, David A, Haasbeek, Cornelis J A, Rodrigues, George B, Dahele, Max, Lock, Michael, Yaremko, Brian, Olson, Robert, Liu, Mitchell, Panarotto, Jason, Griffioen, Gwendolyn H M J, Gaede, Stewart, Slotman, Ben, Senan, Suresh

“…Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for patients with oligometastatic disease. SABR delivers precise, high-dose,…”
Get full text

Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial by Olson, Robert, Senan, Suresh, Harrow, Stephen, Gaede, Stewart, Louie, Alexander, Haasbeek, Cornelis, Mulroy, Liam, Lock, Michael, Rodrigues, George, Yaremko, Brian, Schellenberg, Devin, Ahmad, Belal, Griffioen, Gwendolyn, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Moore, Karen, Currie, Suzanne, Bauman, Glenn, Warner, Andrew, Palma, David

“…Randomized data assessing the longitudinal quality of life (QoL) impact of stereotactic ablative radiation therapy (SABR) in the oligometastatic setting are…”
Get full text

Thecal Sac Contouring as a Surrogate for the Cauda Equina and Intracanal Spinal Nerve Roots for Spine Stereotactic Body Radiation Therapy (SBRT): Contour Variability and Recommendations for Safe Practice by Dunne, Emma M., Lo, Simon S., Liu, Mitchell C., Bergman, Alanah, Kosztyla, Robert, Chang, Eric L., Chang, Ung-Kyu, Chao, Samuel T., Dea, Nicolas, Faruqi, Salman, Ghia, Amol J., Redmond, Kristin J., Soltys, Scott G., Sahgal, Arjun

“…To present interobserver variability in thecal sac (TS) delineation based on contours generated by 8 radiation oncologists experienced in spine stereotactic…”
Get full text

Four‐dimensional dose calculations for dynamic tumour tracking with a gimbal‐mounted linear accelerator by Carpentier, Emilie E., McDermott, Ronan L., Dunne, Emma M., Camborde, Marie‐Laure A., Bergman, Alanah M., Karan, Tania, Liu, Mitchell C. C., Ma, Roy M. K., Mestrovic, Ante

“…Purpose In this study we present a novel method for re‐calculating a treatment plan on different respiratory phases by accurately modeling the panning and…”
Get full text

Population‐based 10‐year oncologic outcomes after low‐dose‐rate brachytherapy for low‐risk and intermediate‐risk prostate cancer by Morris, W. James, Keyes, Mira, Spadinger, Ingrid, Kwan, Winkle, Liu, Mitchell, McKenzie, Michael, Pai, Howard, Pickles, Tom, Tyldesley, Scott

“…BACKGROUND. The objective of this study was to report the rates of disease‐free survival (DFS), cause‐specific survival (CSS), and overall survival after…”
Get full text

Predictive Factors for Acute and Late Urinary Toxicity After Permanent Prostate Brachytherapy: Long-Term Outcome in 712 Consecutive Patients by Keyes, Mira, M.D, Miller, Stacy, M.D, Moravan, Veronika, M.Sc, Pickles, Tom, M.D, McKenzie, Michael, M.D, Pai, Howard, M.D, Liu, Mitchell, M.D.C.M, Kwan, Winkle, M.D, Agranovich, Alexander, M.D, Spadinger, Ingrid, Ph.D, Lapointe, Vincent, M.Sc, Halperin, Ross, M.D, Morris, W. James, M.D

“…Purpose To describe the frequency of acute and late Radiation Therapy Oncology Group (RTOG) urinary toxicity, associated predictive factors, and resolution of…”
Get full text

Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer by Lee, Jeongshim, Kim, Jee Hung, Liu, Mitchell, Bang, Andrew, Olson, Robert, Chang, Jee Suk

“…To report on the local control and toxicity of 5-fraction, high-conformal ultrafractionated radiation therapy (RT) for primary tumors in patients with…”
Get full text

Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors by Zhao, Yizhou, Khawandanh, Eman, Thomas, Steven, Zhang, Susan, Dunne, Emma M, Liu, Mitchell, Schellenberg, Devin

“…For stereotactic body radiotherapy (SBRT) to central (C) and ultracentral (UC) lung tumors, our provincial practice has been to prioritize organs at risk…”
Get full text

Stereotactic Ablative Radiation Therapy for Colorectal Liver Metastases by McDermott, Ronan L, Dunne, Emma M, Zhao, Yizhou, Bergman, Alanah, Liu, Mitchell CC, Schellenberg, Devin, Ma, Roy MK

“…•Stereotactic Ablative Radiation Therapy (SABR) is an effective and well tolerated treatment option for selected patients with liver metastases from colorectal…”
Get full text

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer by Wujanto, Caryn, Vellayappan, Balamurugan, Siva, Shankar, Louie, Alexander V, Guckenberger, Matthias, Slotman, Ben J, Onishi, Hiroshi, Nagata, Yasushi, Liu, Mitchell, Lo, Simon S

“…Metastatic non-small cell lung cancer (NSCLC) is associated with a limited survival when treated with palliative intent platinum-based chemotherapy alone…”
Get full text

Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression by Denault, Marie-Hélène, Feng, Jamie, Kuang, Shelley, Shokoohi, Aria, Leung, Bonnie, Liu, Mitchell, Berthelet, Eric, Laskin, Janessa, Sun, Sophie, Zhang, Tina, Ho, Cheryl, Melosky, Barbara

“…Adjuvant durvalumab after chemoradiotherapy (CRT) is the standard of care for unresectable stage III non-small cell lung cancer (NSCLC). A post hoc exploratory…”
Get full text

Mathematical prediction with pretreatment growth rate of metastatic cancer on outcomes: implications for the characterization of oligometastatic disease by Shin, Yerim, Chang, Jee Suk, Kim, Yeseul, Shin, Sang Joon, Kim, Jina, Kim, Tae Hyung, Liu, Mitchell, Olson, Robert, Kim, Jin Sung, Sung, Wonmo

“…Oligometastatic disease (OMD) represents an indolent cancer status characterized by slow tumor growth and limited metastatic potential. The use of local…”
Get full text

In‐vivo quality assurance of dynamic tumor tracking (DTT) for liver SABR using EPID images by Rostamzadeh, Maryam, Luchka, Kurt, Ma, Roy, Liu, Mitchell, Dunne, Emma, Camborde, Marie‐Laure, Karan, Tania, Mestrovic, Ante, Bergman, Alanah

“…Purpose To assess dynamic tumor tracking (DTT) target localization uncertainty for in‐vivo marker‐based stereotactic ablative radiotherapy (SABR) treatments of…”
Get full text

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5 by Olson, Robert, Liu, Mitchell, Bergman, Alanah, Lam, Sonya, Hsu, Fred, Mou, Benjamin, Berrang, Tanya, Mestrovic, Ante, Chng, Nick, Hyde, Derek, Matthews, Quinn, Lund, Chad, Glick, Daniel, Pai, Howard, Basran, Parminder, Carolan, Hannah, Valev, Boris, Lefresene, Shilo, Tyldesley, Scott, Schellenberg, Devin

“…Oligometastases refer to a state of disease where cancer has spread beyond the primary site, but is not yet widely metastatic, often defined as 1-3 or 1-5…”
Get full text

A Three-Isocenter Jagged-Junction IMRT Approach for Craniospinal Irradiation Without Beam Edge Matching for Field Junctions by Cao, Fred, Ph.D., M.C.C.P.M, Ramaseshan, Ramani, Ph.D., M.C.C.P.M, Corns, Robert, Ph.D., F.C.C.P.M, Harrop, Sheryl, B.Sc, Nuraney, Nimet, B.Sc., R.T.T., C.M.D, Steiner, Peter, R.T.T., B.Sc, Aldridge, Stephanie, R.T.T., B.Sc., M.Ed, Liu, Mitchell, M.D, Carolan, Hannah, M.D, Agranovich, Alex, M.D, Karvat, Anand, M.D

“…Purpose Traditionally craniospinal irradiation treats the central nervous system using two or three adjacent field sets. We propose a technique using a…”
Get full text